|
|
2470 Embarcadero Way
Palo Alto, CA 94303
phone:(650) 320-2100
fax:650-320-2150
|
|
| Symbol |
Private |
| Founded |
2001 |
| Employees |
|
|
|
| www.satietyinc.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Minimally Invasive Treatments for Obesity and Gastrointestinal Conditions |
|
| Management |
| Eric Reuter, President, CEO and Director; Allan Abati, Ph.D., Vice president of Regulatory and Clinical Affairs and Quality Assurance; Rachel Croft, Vice President of Marketing; Robert Gaffney, Vice President of Operations; John Gaiser, Vice President of Research and Development |
| |
|
|
| |
|
| Keywords |
| Obesity, Weight Loss, Restriction |
|
|
|
| Description |
|
Satiety provides a non-surgical, endoscopic and fully transoral procedure enabling similar degrees of weight loss as compared to more invasive restrictive surgeries. |
|
| Technology / Differentiation |
| Company is working on an orally administered device that grabs the stomach walls and staples them to form a smaller pouch. |
|
| Market / Customers |
More than 220,000 patients had surgery for obesity in 2008, with most of these undergoing gastric bypass and gastric banding procedures.
|
|
| Status |
| The company is conducting clinical trials (in which patients have lost a reported 40% of excess weight) and anticipates FDA approval of its product within the next 18-24 months. |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members